Hospital Pharmacy - May 2017 - 339

339

Hager et al.
Table 5. Directors of Pharmacy Survey Results: Positions.
n (%)
In the past 5 years, how many CC pharmacists have left the organization?
In the next 5 years, how many CC positions do you estimate will become available?
How many inpatient pharmacist FTE vacancies do you currently have?
How many CC pharmacist FTE vacancies do you currently have?
How many of your nonadministrative residents do you intend to hire?
Do not have pharmacy residents
0
1-2
3-4
>4
How many of your CC residents do you intend to hire?
Do you plan to expand the number of pharmacy resident positions in the next 5 years?
Yes, ≥3 new positions
Yes, 1-2 positions
No
Do you plan to expand the number of CC pharmacy resident positions in the next 5 years?
Yes, ≥2 new positions
Yes, 1 position
No

Mean ± SD
1.0 ± 1.6
1.3 ± 1.8
1.1 ± 1.9
0.1 ± 0.4

37 (51.4)
6 (8.3)
0 (0)
0 (0)
29 (40.3)
1.0 ± 0.3
10 (12.8)
30 (38.5)
38 (48.7)
1 (1.3)
7 (8.9)
70 (89.7)

Note. CC = critical care; FTE = full-time equivalent.

Table 6. Directors of Pharmacy Survey Results: Pharmacist
Market Perception.
N (%)
How have initial (starting) salaries for residency
trained inpatient pharmacists changed at your
organization?
Increased (>$1000/y)
Remained stable
Decreased (<$1000/y)
Have you had any licensed pharmacists apply for
technician-level positions at your organization?
Yes
No
What is your perception regarding the market for
inpatient pharmacists in your area?
High demand: difficult to fill open positions
Moderate demand: some difficulty filling open
positions
Demand is in balance with supply
Demand is less than the available supply
Demand is much less than the available supply
What is your perception regarding the market for
critical care trained pharmacists in your area?
High demand: difficult to fill open positions
Moderate demand: some difficulty filling open
positions
Demand is in balance with supply
Demand is less than the available supply
Demand is much less than the available supply

28 (38.4)
40 (51.3)
5 (6.4)

4 (5.0)
75 (95.0)

9 (10.7)
22 (26.2)
21 (25.0)
26 (30.9)
6 (7.1)

10 (11.8)
27 (31.8)
25 (29.4)
16 (18.8)
7 (8.2)

there is significantly higher demand in the market place for
critical care trained pharmacists than the CC RPDs. The role
and scope of a critical care pharmacist was not defined in this
analysis, so there may be a difference in the opinions between
the CC RPDs and DOPs. DOPs indicated that critical care
pharmacists could be hired for various positions, even those
outside of critical care. Critical care pharmacists training
may make them a preferred hire for a variety of settings.
Additional review of the definition and scope of a critical
care pharmacist may be necessary, as there appears to be a
discrepancy in opinions.
The extreme dichotomy that existed between the groups
related to potential for dual track degrees likely resulted from
varying interests and areas of day-to-day practice. It is not
surprising that a group of critical care-focused pharmacists
would value the idea of a tracked pharmacy degree that
would allow a student pharmacist to focus primarily on the
clinical care of patients. DOPs may be more broadly engaged
in the clinical and nonclinical experiences of patient care and
not surprisingly have strong feelings against a pharmacy
degree program that would limit exposure to nonclinical
education.
Resident perceptions of critical care training and the job
market have been infrequently examined. A survey conducted
in 2012 included 45 CC PGY2 residents.16 They had high
rates of satisfaction with critical care training, with 91% satisfied with their program and 76% satisfied with their mentorship. Employment status immediately after training was
53.3% clinical pharmacy specialist in critical care, 22.2%



Table of Contents for the Digital Edition of Hospital Pharmacy - May 2017

Editorial, For Sale: FDA Priority Review Vouchers
Current FDA-Related Drug Information; Approvals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals
Summaries of Safety Labeling Changes Approved by the FDA: Boxed Warnings
ISMP Adverse Drug Reactions: Levofloxacin-Induced Neuroexcitation and Hallucinations Statin-Induced Muscle Rupture Mefloquine-Induced Rhabdomyolysis Methimazole-Induced
Critical Care Pharmacist Market Perceptions: Comparison of Critical Care Program Directors and Directors of Pharmacy
Capecitabine, Oxaliplatin, and Bevacizumab (BCapOx) Regimen for Metastatic Colorectal Cancer
Clinical Pharmacy Discharge Counseling Service and the Impact on Readmission Rates in High-Risk Patients
Mannitol Prescribing Practices With Cisplatin Before and After an Educational Newsletter Intervention
Pharmacists’ Knowledge of the Cost of Laboratory Testing
Adverse Drug Reaction Reporting Practices Among United Arab Emirates Pharmacists and Prescribers
Postoperative Pain Management With Liposomal Bupivacaine in Patients Undergoing Orthopedic Knee and Hip Arthroplasty at a Community Hospital
Formulary Drug Reviews
Hospital Pharmacy - May 2017 - 317
Hospital Pharmacy - May 2017 - 318
Hospital Pharmacy - May 2017 - 319
Hospital Pharmacy - May 2017 - 320
Hospital Pharmacy - May 2017 - 321
Hospital Pharmacy - May 2017 - 322
Hospital Pharmacy - May 2017 - 323
Hospital Pharmacy - May 2017 - Editorial, For Sale: FDA Priority Review Vouchers
Hospital Pharmacy - May 2017 - 325
Hospital Pharmacy - May 2017 - Current FDA-Related Drug Information; Approvals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals
Hospital Pharmacy - May 2017 - Summaries of Safety Labeling Changes Approved by the FDA: Boxed Warnings
Hospital Pharmacy - May 2017 - 328
Hospital Pharmacy - May 2017 - 329
Hospital Pharmacy - May 2017 - ISMP Adverse Drug Reactions: Levofloxacin-Induced Neuroexcitation and Hallucinations Statin-Induced Muscle Rupture Mefloquine-Induced Rhabdomyolysis Methimazole-Induced
Hospital Pharmacy - May 2017 - 331
Hospital Pharmacy - May 2017 - 332
Hospital Pharmacy - May 2017 - 333
Hospital Pharmacy - May 2017 - Critical Care Pharmacist Market Perceptions: Comparison of Critical Care Program Directors and Directors of Pharmacy
Hospital Pharmacy - May 2017 - 335
Hospital Pharmacy - May 2017 - 336
Hospital Pharmacy - May 2017 - 337
Hospital Pharmacy - May 2017 - 338
Hospital Pharmacy - May 2017 - 339
Hospital Pharmacy - May 2017 - 340
Hospital Pharmacy - May 2017 - Capecitabine, Oxaliplatin, and Bevacizumab (BCapOx) Regimen for Metastatic Colorectal Cancer
Hospital Pharmacy - May 2017 - 342
Hospital Pharmacy - May 2017 - 343
Hospital Pharmacy - May 2017 - 344
Hospital Pharmacy - May 2017 - 345
Hospital Pharmacy - May 2017 - 346
Hospital Pharmacy - May 2017 - 347
Hospital Pharmacy - May 2017 - Clinical Pharmacy Discharge Counseling Service and the Impact on Readmission Rates in High-Risk Patients
Hospital Pharmacy - May 2017 - 349
Hospital Pharmacy - May 2017 - 350
Hospital Pharmacy - May 2017 - 351
Hospital Pharmacy - May 2017 - 352
Hospital Pharmacy - May 2017 - Mannitol Prescribing Practices With Cisplatin Before and After an Educational Newsletter Intervention
Hospital Pharmacy - May 2017 - 354
Hospital Pharmacy - May 2017 - 355
Hospital Pharmacy - May 2017 - 356
Hospital Pharmacy - May 2017 - Pharmacists’ Knowledge of the Cost of Laboratory Testing
Hospital Pharmacy - May 2017 - 358
Hospital Pharmacy - May 2017 - 359
Hospital Pharmacy - May 2017 - 360
Hospital Pharmacy - May 2017 - Adverse Drug Reaction Reporting Practices Among United Arab Emirates Pharmacists and Prescribers
Hospital Pharmacy - May 2017 - 362
Hospital Pharmacy - May 2017 - 363
Hospital Pharmacy - May 2017 - 364
Hospital Pharmacy - May 2017 - 365
Hospital Pharmacy - May 2017 - 366
Hospital Pharmacy - May 2017 - Postoperative Pain Management With Liposomal Bupivacaine in Patients Undergoing Orthopedic Knee and Hip Arthroplasty at a Community Hospital
Hospital Pharmacy - May 2017 - 368
Hospital Pharmacy - May 2017 - 369
Hospital Pharmacy - May 2017 - 370
Hospital Pharmacy - May 2017 - 371
Hospital Pharmacy - May 2017 - 372
Hospital Pharmacy - May 2017 - 373
Hospital Pharmacy - May 2017 - Formulary Drug Reviews
Hospital Pharmacy - May 2017 - 375
Hospital Pharmacy - May 2017 - 376
Hospital Pharmacy - May 2017 - 377
Hospital Pharmacy - May 2017 - 378
Hospital Pharmacy - May 2017 - 379
Hospital Pharmacy - May 2017 - 380
Hospital Pharmacy - May 2017 - 381
Hospital Pharmacy - May 2017 - 382
Hospital Pharmacy - May 2017 - 383
Hospital Pharmacy - May 2017 - 384
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2019
http://www.nxtbook.com/nxtbooks/sage/fai_201909
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_july2019
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2019
http://www.nxtbook.com/nxtbooks/sage/canadianpharmacistsjournal_05062019
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2019
http://www.nxtbook.com/nxtbooks/sage/sri_supplement_201903
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2019
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2018
http://www.nxtbook.com/nxtbooks/sage/tec_20180810
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2018
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_julyaugust2018
http://www.nxtbook.com/nxtbooks/sage/fai_201807
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2018
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2018
http://www.nxtbook.com/nxtbooks/sage/sri_supplement_201803
http://www.nxtbook.com/nxtbooks/sage/slas_discovery_201712
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2018
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2017
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_november2017
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2017
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_september2017
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_julyaugust2017
http://www.nxtbook.com/nxtbooks/sage/fai_supplement_201709
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2017
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_may2017
http://www.nxtbook.com/nxtbooks/sage/fai_201706
http://www.nxtbook.com/nxtbooks/sage/fai_201607
http://www.nxtbookMEDIA.com